FDA Drug Recalls

Recalls / Class III

Class IIID-0528-2023

Product

Dodex Injectable Cyanocobalamin Injection, USP 1,000 mcg/mL, 25 x1 ML Multiple dose vials, For Intramuscular or Subcutaneous Use Only, Rx Only, Sterile, Manufactured by: Intas Pharmaceuticals Limited Pharmaz Ahnedabad 382 213, INDIA, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, NDC 16729-533-08.

Affected lot / code info
Lot #: R2200394 Exp. 03/2024

Why it was recalled

Sub-potent drug: assay test result below specifications at 9-month timepoint.

Recalling firm

Firm
Accord Healthcare, Inc.
Notification channel
E-Mail
Type
Voluntary: Firm initiated
Address
1009 Slater Rd Ste 210B, Durham, North Carolina 27703-8446

Distribution

Quantity
4574 cartons
Distribution pattern
Nationwide in the USA.

Timeline

Recall initiated
2023-03-29
FDA classified
2023-04-06
Posted by FDA
2023-04-12
Terminated
2025-03-19
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0528-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: drug · FDA Drug Recalls